Skip to content

DRE-NET Study

Drug-Resistant Epiepsy Network Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030250594
Enrollment
540
Registered
2025-12-24
Start date
2026-02-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-resistant epilepsy

Interventions

None listed

Sponsors

Kawashima Masaru
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Non-epilepsy specialist A physician who meets all of the following criteria: Not certified as an epilepsy specialist by the Japan Epilepsy Society. Has treated at least one epilepsy patient aged 15 or older in the past month. Has treated at least one patient with drug-resistant epilepsy (i.e., seizures persist despite trials of two appropriate anti-seizure medications) in the past 12 months. Epilepsy specialist A physician who meets all of the following criteria: Certified as an epilepsy specialist by the Japan Epilepsy Society. Has treated at least one epilepsy patient aged 15 or older in the past month. Has treated at least one patient with drug-resistant epilepsy in the past 12 months.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
We will investigate the following items. Note that only respondents who meet the selection criteria will answer questions related to actual treatment practices for patients with drug-resistant epilepsy. Physician attributes (e.g., gender, affiliated institution, membership in academic societies, board certification status) Patient characteristics in clinical practice (e.g., number of patients seen per month, number of patients with persistent seizures) Perceptions regarding the treatment of drug-resistant epilepsy (knowledge and attitude) (e.g., awareness of the definition of drug-resistant epilepsy, timing considered appropriate for referral to an epilepsy specialist) Actual treatment practices for patients with drug-resistant epilepsy (practice) (e.g., proportion of patients referred to epilepsy specialists, reasons for referral, presence of psychological barriers to referral, proportion of patients referred back from specialists, time taken before referral to a specialist)

Contacts

Public ContactReina Makino

ONO PHARMACEUTICAL CO., LTD.

r.makino@ono-pharma.com+81-6-6263-5670

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026